This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Apajalahti, S. Articles by Ingman, T. Search for Related Content PubMed PubMed Citation Articles by Apajalahti, S. Articles by Ingman, T. Social Bookmarking                         What's this?

The in vivo Levels of Matrix Metalloproteinase-1 and -8 in Gingival Crevicular Fluid during Initial Orthodontic Tooth Movement

¹ Department of Pedodontics and Orthodontics, Institute of Dentistry, Biomedicum Helsinki (4th floor, C407b), POB 63, 00014 University of Helsinki, Helsinki, Finland;
² Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital (HUCH), Institute of Dentistry, University of Helsinki, the Orton Research Institute and the Orthopedic Hospital of the Invalid Foundation, Helsinki, Finland; and
³ Department of Health, City of Helsinki, Finland;

View larger version (10K): [in this window] [in a new window]   Figure 1. The concentrations of MMP-8 (mean + SD) in the GCF of orthodontic (n = 11) and control patients (n = 6) detected with the IFMA analysis. The orthodontic samples (on the left) were collected from the orthodontically moved teeth immediately before fixed appliance activation (0 hr), and at 1-8 hrs after force application. Control GCF samples were collected from the non-orthodontic control patients. The mean GCF MMP-8 concentrations for orthodontically treated teeth at 4-8 hrs were significantly higher than before activation, and when compared with control teeth (Mann-Whitney U-test; p < 0.05).

View larger version (32K): [in this window] [in a new window]   Figure 2. Molecular forms and expression of MMP-1 and MMP-8 in GCF from the orthodontic and control patients detected by the Western blot method. (A) Western blot with MMP-8 specific antibody. Positions of molecular-weight markers (kDa) are indicated on the left. GCF samples were collected from the teeth undergoing orthodontic tooth movement immediately before (0 hr) and at 1-8 hrs after activation of fixed appliances. MMP-8 expression is undetectable before orthodontic force (0 hr); however, it is markedly increased after force application (1-8 hrs). PMN indicates culture supernatant of human neutrophils used as positive control for MMP-8. Bands in the range 75 to 80 kDa corresponding to PMN-type pro-MMP-8 are present at 1-8 hrs, whereas PMN active enzyme (60 kDa) is present at 4 hrs and at 7-8 hrs. Low-molecular-weight staining at < 30 kDa, representing degraded fragments of MMP-8, is present at 6-8 hrs. (B) Barely detectable MMP-8 immunoreactivity is seen in GCF control samples. (C) No MMP-1 immunoreactivity is detectable in the Western blots of the orthodontic GCF with MMP-1 specific antibody. As for positive control, MMP-1 from human rheumatoid synovial fibroblasts was used (F). (D) GCF control samples show no MMP-1 immunoreactivity.

Journal of Dental Research, Vol. 82, No. 12, 1018-1022 (2003)
DOI: 10.1177/154405910308201216


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?